Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX

BACKGROUND/AIMS: There has been growing evidence on the utility of neoadjuvant FOLFIRINOX in borderline resectable (BR) or locally advanced (LA) pancreatic cancer. However, factors predicting survival in these patients remain to be identified, and we aimed to identify these prognostic factors. METHO...

全面介紹

Na minha lista:
書目詳細資料
發表在:Gut Liver
Main Authors: Choi, Young Hoon, Lee, Sang Hyub, You, Min Su, Shin, Bang Sup, Paik, Woo Hyun, Ryu, Ji Kon, Kim, Yong-Tae, Kwon, Wooil, Jang, Jin-Young, Kim, Sun-Whe
格式: Artigo
語言:Inglês
出版: Editorial Office of Gut and Liver 2021
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7960979/
https://ncbi.nlm.nih.gov/pubmed/32235008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl19182
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍